Protalix BioTherapeutics announced it has completed enrollment of its Phase 3 trial evaluating PRX-102 in Fabry disease patients previously treated with…
Articles by Patricia Inácio, PhD
A case study detailing a younger man admitted to a hospital for a stroke — later attributed to Fabry disease…
A new diagnostic tool that can screen for up to six lysosomal storage disorders, including Fabry disease, in…
A recent review has summarized the current diagnostic tools and available treatments for Fabry disease, highlighting the challenges and potential…
An enzyme structurally similar to alpha-galactosidase A (GLA), present in a close relative of the tobacco plant, was able to rescue Fabry…
Galafold (migalastat) capsules of 123 mg were approved in Japan to treat Fabry disease patients, ages 16 and older,…
Measuring left heart chamber size and functioning could help doctors do a better job of tracking the progression of Fabry…
Amicus Therapeutics recently submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for its investigational oral…